AI-Engineered Formulation Chemicals Market, By Type (Software, Hardware, Services), By Application (Production Optimization, New Material Innovation…
Report Code : CHR2
No. of Pages : 200
Date : Feb 2026
U.S. peripheral vascular devices market valued at $5.26B in 2025, projected to reach $9.84B by 2035 at 6.7% CAGR; historical review covers 2021–2024.
Report Code : US181
No. of Pages : 150
Date : Feb 2026
U.S. bare metal stent devices market valued at $1.05B in 2025, projected to reach $1.38B by 2035 at 2.9% CAGR; historical review covers 2021–2024.
Report Code : US180
No. of Pages : 150
Date : Feb 2026
U.S. drug-eluting stent devices market valued at $4.31B in 2025, projected to reach $7.42B by 2035 at 5.6% CAGR; historical review covers 2022–2024.
Report Code : US179
No. of Pages : 150
Date : Feb 2026
U.S. coronary stent devices market valued at $7.82B in 2025, projected to reach $14.92B by 2035 at 6.84% CAGR; historical review covers 2021–2024.
Report Code : US178
No. of Pages : 150
Date : Feb 2026
U.S. cardiac catheterization devices market valued at $13.52B in 2025, projected to reach $28.74B by 2035 at 7.62% CAGR; historical 2021–2024.
Report Code : US177
No. of Pages : 150
Date : Feb 2026
U.S. electrophysiology devices market valued at $6.28B in 2025, projected to reach $14.62B by 2035 at 8.94% CAGR; historical review covers 2021–2024.
Report Code : US176
No. of Pages : 150
Date : Feb 2026
U.S. cardiac ablation devices market valued at $2.95B in 2025, projected to reach $6.82B by 2035 at 8.74% CAGR; historical review covers 2021–2024.
Report Code : US175
No. of Pages : 150
Date : Feb 2026
U.S. transcatheter heart valve devices market valued at $6.18B in 2025, projected to reach $16.94B by 2035 at 10.62% CAGR; historical 2021–2024.
Report Code : US174
No. of Pages : 150
Date : Feb 2026
U.S. structural heart devices market valued at $7.42B in 2025, projected to reach $17.96B by 2035 at 9.27% CAGR; historical review covers 2021–2024.
Report Code : US173
No. of Pages : 150
Date : Feb 2026